Cardiac Computed Tomography & Angiography (CCTA)

LCD Information Document Information Source LCD ID N/A LCD ID L33423 Original ICD-9 LCD ID Not Applicable LCD Title Cardiac Computed Tomography & Angiography (CCTA) Proposed LCD in Comment Period N/A Source Proposed LCD DL33423 Opens in a new window Original Effective Date For services performed on or after 10/01/2015 Revision Effective Date For services performed on or after 06/26/2025 Revision Ending Date N/A Retirement Date N/A Notice Period Start Date 08/03/2017 Notice Period End Date 09/17/2017 CPT codes, descriptions, and other data only are copyright 2025 American Medical Association. All Rights Reserved. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. CPT is a registered trademark of the American Medical Association. Current Dental Terminology © 2025 American Dental Association. All rights reserved. Copyright © 2026, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at ub04@aha.org or 312‐422‐3366. Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates. Issue Issue Description This LCD outlines limited coverage for this service with specific details under Coverage Indications, Limitations and/or Medical Necessity. Issue - Explanation of Change Between Proposed LCD and Final LCD CMS National Coverage Policy Title XVIII of the Social Security Act, §1862 (a)(1)(A) allows coverage and payment for only those services that are considered to be reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.Title XVIII of the Social Security Act, §1862 (a)(1)(D) Investigational or Experimental. Title XVIII of the Social Security Act, §1862 (a)(7) Excludes routine physical examinations. 42 CFR §410.32 Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions. CMS Internet-Only Manual, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 4, §220.1 Computed Tomography (CT) Coverage Indications, Limitations, and/or Medical Necessity Cardiac computed tomographic angiography (CCTA), also known as computed tomography (CT) of the heart and coronary arteries or multidetector computed cardiac tomography (MDCT), is considered reasonable and necessary for the evaluation of suspected symptomatic coronary artery disease (CAD) and for the detection of structural and morphologic intra- and extra-cardiac conditions. Use of a CCTA is expected to avoid diagnostic cardiac catheterization. If high pre-test probability of CAD exists, this A/B MAC expects the patient to undergo invasive coronary angiography with appropriate percutaneous coronary intervention.To establish CCTA medical necessity, your case must meet at least 1 indication in the following: A. Symptomatic (CAD) and/or B. Suspected Cardiac Structural/Morphologic Anomalies:A. Symptomatic (CAD)1. Evaluation of acute chest pain, unexplained dyspnea or symptoms suggesting angina pectoris (such as jaw pain) when there is: a. Intermediate pre-test probability of CAD* and No electrocardiogram (EKG) changes to suggest acute myocardial injury or ischemia and Normal initial cardiac markers. OR b. Patients with intermediate risk and a discordant clinical situation (e.g., ongoing ischemic symptoms, normal stress test). 2. Evaluation of chest pain syndrome when there is: Intermediate pre-test probability of CAD* and Uninterpretable EKG** or patient is unable to exercise or Uninterpretable or equivocal stress test (exercise, perfusion or stress echocardiogram (echo)). *Intermediate pretest probability of CAD by age, sex and symptoms is between 10% and 90%, as referenced in the American College of Coronary Foundation/American College of Radiology (ACCF/ACR) 2006 appropriateness criteria for cardiac CT and cardiac magnetic resonance imaging (MRI).** Uninterpretable EKG refers to EKGs with resting ST segment depression greater than or equal to 0.10 mV, complete left bundle branch block, pre-excitation or paced rhythm.3. Evaluation of intracardiac structures for suspected coronary anomalies.B. Suspected Cardiac Structural/Morphologic Anomalies1. Detection of intracardiac and extracardiac structures in: Evaluation of cardiac mass (suspected tumor or thrombus) or Evaluation of pericardial conditions (mass, constrictive pericarditis or complications of cardiac surgery) or Patients with technically limited images from echo, MRI or transesophageal echocardiography (TEE). 2. Detection of morphologic intracardiac and extracardiac structures for: Evaluation of pulmonary vein anatomy prior to invasive radiofrequency ablation for atrial fibrillation. While data is limited for 3-dimensional (3D) reconstruction of the left atrium for ablations, there is broad consensus among cardiologists that these images, which are integrated and used in real-time in the procedure room to shorten procedure time, improve therapeutic success and enhance patient safety or Non-invasive coronary vein mapping prior to placement of biventricular pacemaker or Non-invasive coronary arterial mapping, including internal mammary artery, prior to repeat cardiac surgical revascularization or Detection of complex congenital heart disease, including anomalies of coronary circulation, great vessels and cardiac chamber and valves or Evaluation of coronary arteries in patients with new onset heart failure to assess etiology. Limitations:1. Coverage of CCTA is limited to CT devices that process thin, high resolution slices. Decreased resolution and slower rotation speeds result in a higher number of non-evaluable segments. At the current time, Medicare requires the multidetector scanner to have collimation of 0.625 mm or less and a rotational speed of 375 msec or less OR to have at least 64 slice detector design. Do not submit studies from scanners that do not meet these requirements.2. Medicare does not cover a screening CCTA for asymptomatic patients, for risk stratification or for quantitative evaluation of coronary calcium. This Local Coverage Determination (LCD) does not address Heartflow determinations.Ultrafast CT scan of the heart electron-beam tomography (EBT) or electron-beam computed tomography (EBCT) is not a covered service. 3. Simultaneous exclusion of obstructive CAD, pulmonary embolism and aortic dissection (“triple rule-out”) in the emergency department is not covered. In order to optimize imaging of the right coronary artery (RCA), contrast must be cleared from the right sided chambers during acquisition, a process that leads to suboptimal contrast timing in the pulmonary arteries. Simultaneous rule-out of aortic pathology (at the low pitch needed to properly image the coronaries) mandates thicker slices in order to capture the total volume required in a reasonable breath hold. The increased slice thickness degrades coronary image quality.4. CCTA patients must be able to lie still, follow breathing instructions and take nitroglycerin for coronary dilatation.5. Prior to the initiation of a CCTA, the physician must make an assessment of the anatomic location, degree and intensity of calcification and impact of the calcification on the utility of the test results. CCTAs performed on patients with elevated quantitative calcium scores that preclude accurate assessment of coronary anatomy are not covered by Medicare. Summary of Evidence N/A Analysis of Evidence (Rationale for Determination) N/A

Cardiac computed tomographic angiography (CCTA), also known as computed tomography (CT) of the heart and coronary arteries or multidetector computed cardiac tomography (MDCT), is considered reasonable and necessary for the evaluation of suspected symptomatic coronary artery disease (CAD) and for the detection of structural and morphologic intra- and extra-cardiac conditions. Use of a CCTA is expected to avoid diagnostic cardiac catheterization. If high pre-test probability of CAD exists, this A/B MAC expects the patient to undergo invasive coronary angiography with appropriate percutaneous coronary intervention. To establish CCTA medical necessity, your case must meet at least 1 indication in the following: A. Symptomatic (CAD) and/or B. Suspected Cardiac Structural/Morphologic Anomalies: A. Symptomatic (CAD) 1. Evaluation of acute chest pain, unexplained dyspnea or symptoms suggesting angina pectoris (such as jaw pain) when there is: a. Intermediate pre-test probability of CAD* and No electrocardiogram (EKG) changes to suggest acute myocardial injury or ischemia and Normal initial cardiac markers. OR b. Patients with intermediate risk and a discordant clinical situation (e.g., ongoing ischemic symptoms, normal stress test). 2. Evaluation of chest pain syndrome when there is: Intermediate pre-test probability of CAD* and Uninterpretable EKG** or patient is unable to exercise or Uninterpretable or equivocal stress test (exercise, perfusion or stress echocardiogram (echo)). *Intermediate pretest probability of CAD by age, sex and symptoms is between 10% and 90%, as referenced in the American College of Coronary Foundation/American College of Radiology (ACCF/ACR) 2006 appropriateness criteria for cardiac CT and cardiac magnetic resonance imaging (MRI). ** Uninterpretable EKG refers to EKGs with resting ST segment depression greater than or equal to 0.10 mV, complete left bundle branch block, pre-excitation or paced rhythm. 3. Evaluation of intracardiac structures for suspected coronary anomalies. B. Suspected Cardiac Structural/Morphologic Anomalies 1. Detection of intracardiac and extracardiac structures in: Evaluation of cardiac mass (suspected tumor or thrombus) or Evaluation of pericardial conditions (mass, constrictive pericarditis or complications of cardiac surgery) or Patients with technically limited images from echo, MRI or transesophageal echocardiography (TEE). 2. Detection of morphologic intracardiac and extracardiac structures for: Evaluation of pulmonary vein anatomy prior to invasive radiofrequency ablation for atrial fibrillation. While data is limited for 3-dimensional (3D) reconstruction of the left atrium for ablations, there is broad consensus among cardiologists that these images, which are integrated and used in real-time in the procedure room to shorten procedure time, improve therapeutic success and enhance patient safety or Non-invasive coronary vein mapping prior to placement of biventricular pacemaker or Non-invasive coronary arterial mapping, including internal mammary artery, prior to repeat cardiac surgical revascularization or Detection of complex congenital heart disease, including anomalies of coronary circulation, great vessels and cardiac chamber and valves or Evaluation of coronary arteries in patients with new onset heart failure to assess etiology. Limitations: 1. Coverage of CCTA is limited to CT devices that process thin, high resolution slices. Decreased resolution and slower rotation speeds result in a higher number of non-evaluable segments. At the current time, Medicare requires the multidetector scanner to have collimation of 0.625 mm or less and a rotational speed of 375 msec or less OR to have at least 64 slice detector design. Do not submit studies from scanners that do not meet these requirements. 2. Medicare does not cover a screening CCTA for asymptomatic patients, for risk stratification or for quantitative evaluation of coronary calcium. This Local Coverage Determination (LCD) does not address Heartflow determinations. Ultrafast CT scan of the heart electron-beam tomography (EBT) or electron-beam computed tomography (EBCT) is not a covered service. 3. Simultaneous exclusion of obstructive CAD, pulmonary embolism and aortic dissection (“triple rule-out”) in the emergency department is not covered. In order to optimize imaging of the right coronary artery (RCA), contrast must be cleared from the right sided chambers during acquisition, a process that leads to suboptimal contrast timing in the pulmonary arteries. Simultaneous rule-out of aortic pathology (at the low pitch needed to properly image the coronaries) mandates thicker slices in order to capture the total volume required in a reasonable breath hold. The increased slice thickness degrades coronary image quality. 4. CCTA patients must be able to lie still, follow breathing instructions and take nitroglycerin for coronary dilatation. 5. Prior to the initiation of a CCTA, the physician must make an assessment of the anatomic location, degree and intensity of calcification and impact of the calcification on the utility of the test results. CCTAs performed on patients with elevated quantitative calcium scores that preclude accurate assessment of coronary anatomy are not covered by Medicare.